DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ZIPRASIDONE HYDROCHLORIDE

« Back to Dashboard

All Clinical Trials for Ziprasidone Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00014001	CATIE- Schizophrenia Trial	Completed	National Institute of Mental Health (NIMH)	Phase 4	2000-12-01	The CATIE Schizophrenia Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project. The schizophrenia trial is being conducted to determine the long-term effects and usefulness of antipsychotic medications in persons with schizophrenia. It is designed for people with schizophrenia who may benefit from a medication change. The study involves the newer atypical antipsychotics (olanzapine, quetiapine, risperidone, clozapine, and ziprasidone)and the typical antipsychotics (perphenazine and fluphenazine decanoate). All participants will receive an initial comprehensive medical and psychiatric evaluation and will be closely followed throughout the study. For most participants the study will last up to 18 months. Everyone in the study will be offered an educational program about schizophrenia and family members will be encouraged to participate.
NCT00034801	Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia	Completed	Eli Lilly and Company	Phase 4	2001-09-01	This is a research study comparing the safety and efficacy of two active study medications
NCT00044655	Switching Medication to Treat Schizophrenia	Completed	National Institute of Mental Health (NIMH)	Phase 4	2001-07-01	This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.

Clinical Trial Conditions for Ziprasidone Hydrochloride

Condition Name

Condition Name for Ziprasidone Hydrochloride
Intervention	Trials
Schizophrenia	68
Bipolar Disorder	36
Schizoaffective Disorder	20

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ziprasidone Hydrochloride
Intervention	Trials
Schizophrenia	71
Disease	43
Psychotic Disorders	41

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ziprasidone Hydrochloride

Trials by Country

Trials by Country for Ziprasidone Hydrochloride
Location	Trials
United States	475
Canada	23
India	23
Spain	23
Brazil	19

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ziprasidone Hydrochloride
Location	Trials
New York	30
California	30
Ohio	24
Texas	23
Florida	21

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ziprasidone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Ziprasidone Hydrochloride
Clinical Trial Phase	Trials
Phase 4	62
Phase 3	38
Phase 2/Phase 3	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ziprasidone Hydrochloride
Clinical Trial Phase	Trials
Completed	102
Terminated	15
Recruiting	13

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ziprasidone Hydrochloride

Sponsor Name

Sponsor Name for Ziprasidone Hydrochloride
Sponsor	Trials
Pfizer	73
National Institute of Mental Health (NIMH)	8
Massachusetts General Hospital	6

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ziprasidone Hydrochloride
Sponsor	Trials
Other	133
Industry	94
NIH	10

Export unavailable in trial.
Subscribe for complete access.